Skip to main content
. 2019 Jul 5;13(7):e0007337. doi: 10.1371/journal.pntd.0007337

Table 2. Mozambique districts, populations, sample sizes and study results July 2016*.

Province with Districts Population Number of Supervision Areas Sample
Size
Took ALB and IVM Weighted Verified Coverage (95%CI)(95% CI)
Classification DR = 13
Reported Coverage
Cabo Delgado 450,161 5 95 72 76.9%
(± 8.5%)
94%
Moc Praia 110,795 1 19 15 Pass
Mueda 131,723 2 19 16/14 Pass
Nangade 73,378 1 19 16 Pass
Palma 53,576 1 19 11 Fail
Niassa 331,335 4 76 63 81.5%
(± 9.9%)
88%
Cuamba 249,843 2 38 16/15 Pass
Maúa 63,755 1 19 15 Pass
Mecula 17,738 1 19 17 Pass
Nampula 1,713,489 8 152 101 65.9%
(± 8.3%)
92%
Larde** 89,203 1 19 10 Fail
Liupo** 82,624 1 19 12 Fail
Mogincual 106,056 1 19 14 Pass
Mogovolas 430,083 1 19 16 Pass
Moma** 375,901 1 19 7 Fail
Monapo 384,171 1 19 13 Pass
Muecate 116,887 1 19 14 Pass
Nacaroa 128,534 1 19 15 Pass
Zambezia 416,523 4 76 66 86.8%
(± 8.5%)
100%
Inhassunge 103,741 2 38 17/16 Pass
Mopeia 160,795 1 19 16 Pass
Namarrói 151,987 1 19 17 Pass
Total 2,911,478 21 399 302 72.2%
(±1.8%)
95%

*ALB = Albendazole, IVM = Ivermectin, CI = Confidence Interval

** Districts re-treated and the LQAS survey repeated.